Mizuho Securities Downgrades Universal Health Services (UHS) to Neutral Following Trump Win
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Mizuho Securities downgraded Universal Health Services (NYSE: UHS) from Buy to Neutral with a price target of $133.00.
Analyst Ann Hynes commented, "We are downgrading our ACA vulnerable stocks (UHS, AMSG and MD) to Buy from Neutral given President-elect Trump's pledge to repeal and replace Obamacare. Even though it is yet seen if he will be able to claw back an entitlement as big as Obamacare, the fear itself will weigh on valuations and, as a result, we no believe these stocks can outperform until we receive clarity on his true intentions."
Shares of Universal Health Services closed at $128.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Cuts Teva Pharma (TEVA) to Neutral Amid Challenging Generic Environment
- Bassett Furniture (BSET) PT Raised to $28 at Stifel Following 4Q EPS Beat
- UPDATE: SunTrust Robinson Humphrey Downgrades Corporate Office Properties Trust (OFC) to Hold
Create E-mail Alert Related CategoriesAnalyst Comments, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!